Boston Scientific Corporation (BSX) Shares are Down -0.58%

Boston Scientific Corporation (BSX) has risen sharply, recording gains of 1% in the past 4 weeks. However, the stock has corrected -0.58% in the past 1 week, providing a good buying opportunity on dips. Boston Scientific Corporation (BSX) : During the past 4 weeks, traders have been relatively bearish on Boston Scientific Corporation (BSX), hence the stock is down -1.45% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1% relative to the S&P 500.

Boston Scientific Corporation (NYSE:BSX): The stock was completely flat for the day, closing at $24.14 on Friday. The flat closing masks the intraday volatility in the stock. After opening at $24.16, the stock touched an intraday high of $24.24 and a low of $24.07. Neither the bulls nor the bears asserted their supremacy at close, due to which the stock closed completely flat. The stock previously closed at $24.14. The total trading volume on Friday was 5,602,208.

The stock has recorded a 20-day Moving Average of 0.95% and the 50-Day Moving Average is 3.7%. Boston Scientific Corporation is up 9.58% in the last 3-month period. Year-to-Date the stock performance stands at 30.91%.

Boston Scientific Corporation (BSX) : Average target price received by Boston Scientific Corporation (BSX) is $26.03 with an expected standard deviation of $2.96. The most aggressive target on the stock is $30, whereas the most downbeat target is $20. 18 financial analysts are currently covering the stock.


Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Womens Health, and Neuromodulation.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.